InnoCare Pharma Limited (INCPF)

PNK: INCPF · Real-Time Price · USD

3.26

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

InnoCare Pharma Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q3 2019	Q4 2018
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Sep 30, 2019	Dec 31, 2018
Cash & Equivalents	6.9B	8.2B	8.29B	8.26B	8.37B	8.54B	8.7B	8.67B	5.96B	5.93B	6.25B	3.97B	4.41B	2.29B	2.35B	1.88B
Short-Term Investments	642.94M	n/a	n/a	323.29M	321.58M	317.86M	313.29M	n/a	246.24M	317.06M	n/a	n/a	30.14M	80.35M	90.39M	169.05M
Long-Term Investments	n/a	4.32M	5.66M	8.19M	-311.95M	11M	-301.58M	327.58M	77.74M	9.04M	n/a	n/a	-28.98M	-79.19M	-89.23M	-167.9M
Other Long-Term Assets	n/a	51.19M	6.91M	-200.76M	32.83M	-211.45M	326.38M	-188.55M	75.17M	326.44M	15.75M	1.16M	48.24M	111.21M	122.84M	170.38M
Receivables	326.57M	234.76M	276.38M	n/a	209.27M	153.74M	127.82M	127.44M	72.1M	45.27M	22.82M	152K	58K	37K	27K	44K
Inventory	118.38M	118.16M	119.09M	116.91M	109.48M	98.92M	65.32M	48.19M	20.28M	9.92M	6.74M	1.88M	n/a	n/a	n/a	n/a
Other Current Assets	14.63M	67.76M	382.59M	382.92M	276.31M	382.64M	189.61M	320.48M	114.59M	116.14M	119.57M	120.56M	49.66M	23.39M	33.59M	14.5M
Total Current Assets	8.07B	8.62B	8.77B	8.95B	9.11B	9.18B	9.3B	9.16B	6.41B	6.42B	6.4B	4.09B	4.5B	2.41B	2.48B	2.06B
Property-Plant & Equipment	1.1B	823.44M	833.94M	751.5M	995.09M	696.52M	952.21M	597M	792.03M	502.37M	523.22M	329.35M	243.7M	58.42M	103.32M	17.96M
Goodwill & Intangibles	39.67M	266.62M	42.13M	269.16M	41.76M	273.73M	44.43M	267.11M	35.13M	142.57M	39.4M	114.97M	40.06M	116.5M	39.96M	117.21M
Total Long-Term Assets	1.61B	1.15B	1.15B	1.09B	1.08B	1.04B	1.02B	1.27B	1.23B	980.42M	578.37M	445.48M	303.03M	206.95M	176.89M	137.66M
Total Assets	9.68B	9.77B	9.92B	10.04B	10.19B	10.22B	10.32B	10.43B	7.64B	7.4B	6.98B	4.54B	4.8B	2.62B	2.66B	2.2B
Account Payables	117.24M	118.71M	134.9M	113.91M	129.43M	148.94M	118.6M	99.58M	92.02M	84.6M	14.74M	5.52M	9.53M	8.2M	5.89M	2.19M
Deferred Revenue	n/a	27.32M	1.00	23.88M	n/a	22.02M	280.03M	10.29M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.28B	n/a	1.26B	25.19M	1.23B	n/a	1.2B	n/a	n/a	n/a	n/a	n/a	n/a	9.1M	9.2M	59.28M
Other Current Liabilities	511.38M	1.91B	679.73M	1.68B	10.88M	1.85B	522.91M	643.22M	126.79M	126.86M	71.66M	41.89M	44.45M	32.1M	1.05M	534K
Total Current Liabilities	2.11B	2.06B	2.08B	2.02B	2.07B	2.04B	2.08B	802.53M	304.34M	329.3M	143.5M	104.45M	66.19M	65.67M	38.56M	72.29M
Long-Term Debt	33.9M	33.1M	26.3M	22.2M	7.7M	292.05M	n/a	1.51B	1.22B	1.2B	1.17B	1.15B	1.15B	1.12B	1B	957.27M
Other Long-Term Liabilities	294.05M	588.1M	305.58M	300.98M	296.45M	289.49M	287.76M	294.75M	556.27M	161.3M	n/a	n/a	n/a	4.38B	3.09B	2B
Total Long-Term Liabilities	626.1M	656.87M	375.52M	636.37M	615.01M	611.28M	601.4M	1.85B	1.82B	1.41B	1.33B	1.27B	1.31B	5.5B	4.09B	2.97B
Total Liabilities	2.74B	2.71B	2.46B	2.66B	2.69B	2.65B	2.68B	2.65B	2.12B	1.74B	1.48B	1.38B	1.38B	5.56B	4.13B	3.04B
Total Debt	1.39B	68.76M	1.65B	73.49M	1.29B	341.06M	1.25B	1.57B	1.28B	1.27B	1.25B	1.17B	1.16B	1.14B	1.02B	1.03B
Common Stock	23K	23.32K	23.32K	23.33K	23K	23.18K	23K	23.17K	19K	19K	19K	16K	16K	4K	4K	3K
Retained Earnings	-5.32B	-5.22B	-5.08B	-4.98B	-4.85B	-4.46B	-4.42B	-4.4B	-3.98B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Comprehensive Income	n/a	12.25B	275.75M	12.32B	391.72M	11.98B	12.05B	12.13B	37.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	6.91B	7.02B	7.15B	7.34B	7.46B	7.52B	7.6B	7.74B	5.47B	5.6B	5.45B	3.1B	3.37B	-3B	-1.54B	-904.3M
Total Investments	405.14M	4.32M	5.66M	331.48M	9.63M	328.86M	11.71M	327.58M	323.98M	326.1M	2.01M	1.16M	1.16M	1.16M	1.16M	1.16M